novartis - dofaq.co
Nagyot lép a Novartis Magyarországon
Portfolio - 05 May 2023
Nagyot lép a Novartis Magyarországon ...
Novartis pays PeptiDream $180M as radiopharma big bang continues
Fierce Biotech - 30 Apr 2024
Novartis pays PeptiDream $180M as radiopharma big bang continues ...
Leading Thru' Innovation: Colette Matz Discusses Novartis Hungary's Plans - BBJ
Budapest Business Journal - 27 Apr 2024
Leading Thru' Innovation: Colette Matz Discusses Novartis Hungary's Plans - BBJ ...
Együttműködést írt alá a Semmelweis Egyetem, az ITM és a Novartis egy innovatívabb közegészségügyért
Semmelweis Egyetem - 22 Mar 2022
Együttműködést írt alá a Semmelweis Egyetem, az ITM és a Novartis egy innovatívabb közegészségügyért ...
Novartis, PeptiDream Ink Potential $2.7B Deal to Expand Radioligand Discovery Partnership
BioSpace - 30 Apr 2024
Novartis, PeptiDream Ink Potential $2.7B Deal to Expand Radioligand Discovery Partnership ...
PeptiDream Expands Peptide Discovery Collaboration With Novartis
Contract Pharma - 30 Apr 2024
PeptiDream Expands Peptide Discovery Collaboration With Novartis ...
Stock Watch: Novartis And The Changing Face Of Big Pharma
Scrip - 30 Apr 2024
Stock Watch: Novartis And The Changing Face Of Big Pharma ...
Morphosys says takeover by Novartis on course after report of drug safety concern
Reuters - 29 Apr 2024
Morphosys says takeover by Novartis on course after report of drug safety concern ...
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition
STAT - 28 Apr 2024
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition ...
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis
Business Wire - 30 Apr 2024
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis ...
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia
Fierce Pharma - 26 Apr 2024
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia ...
Research and development
Novartis - 08 Feb 2024
Research and development ...
Novartis reports 25% increase in net income in Q1 2024
Pharmaceutical Technology - 24 Apr 2024
Novartis reports 25% increase in net income in Q1 2024 ...
Morphosys says Novartis takeover progressing as planned for H1 2024
XM - 29 Apr 2024
Morphosys says Novartis takeover progressing as planned for H1 2024 ...
A legmodernebb génterápiák Magyarországra is megérkezhetnek - Interjú a Novartis hazai vezérével
Portfolio - 31 May 2022
A legmodernebb génterápiák Magyarországra is megérkezhetnek - Interjú a Novartis hazai vezérével ...
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT
BioSpace - 29 Apr 2024
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT ...
From black holes to AI driven drug discovery – collaboration wins the day
Novartis - 29 Apr 2024
From black holes to AI driven drug discovery – collaboration wins the day ...
Novartis nominates ex-BMS chief Giovanni Caforio as its next chair
Fierce Pharma - 23 Apr 2024
Novartis nominates ex-BMS chief Giovanni Caforio as its next chair ...
Novartis in Society Integrated Report
Novartis - 31 Jan 2024
Novartis in Society Integrated Report ...